Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05563090
Other study ID # SCHMI-2022-001
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 17, 2022
Est. completion date December 31, 2024

Study information

Verified date December 2023
Source Singapore Chung Hwa Medical Institution
Contact Hui Ping Ng, MD
Phone 98759418
Email huanghuiping@singaporetcm.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators aim to objectively identify the Traditional Chinese Medicine (TCM) syndrome differentiation of type II diabetic and prediabetic patients in Singapore through modern technologies thereby potentially increasing the accuracy of identification, diagnosis, and prevention of diabetes and prediabetes through a system of targeted treatment. This observational study integrates the concept of TCM diagnostic methods with modern tools aim to provide an objective view on the syndrome differentiation of diabetic and prediabetic patients in Singapore and hence provide a guideline in the treatment options targeted specifically at Singaporeans demographic. A total of 250 subjects with 50 allocated in each group will be recruited to ensure a sufficient sample size for statistical analysis of the diabetic and prediabetic syndrome differentiation. Subjects aged 21-65 years old, of either gender, with no limitations on race, and is diagnosed with either diabetes (FPG ≥ 7.0 mmol/L, or 2hPG ≥ 11.1mmol) or prediabetes (IFG of FPG 6.1-6.9 mmol/L, and/or IGT with 2hPG of 7.8-11.0 mmol/L) will be included. Subjective and objective assessments through health evaluation, Physical Activity Questionnaire and Sugar Intake, Constitution in Chinese Medicine Questionnaire, radial pulse diagnosis and tongue diagnosis will be performed for each subject in a single visit. Statistical analysis of assessments will be conducted using unpaired t-test with significance level of p<0.05. Statistical software SPSS 15.0 (SPSS Inc.) will be used for the analysis.


Description:

Singapore's age-adjusted comparative prevalence of diabetes is at 5.5% in 2019 down from 10.2% in 2010, whereas the global average is at 8.3%. However, approximately 640,000 Singapore citizens 18 years and above are diagnosed with diabetes, and around 650,000 citizens are prediabetic. The investigators aim to objectively identify the Traditional Chinese Medicine (TCM) syndrome differentiation of type II diabetic and prediabetic patients in Singapore through modern technologies thereby potentially increasing the accuracy of identification, diagnosis, and prevention of diabetes and prediabetes through a system of targeted treatment. The investigators hypothesize that the TCM syndrome differentiation of 'xiao-ke' in Singapore is different from that of the ones defined in TCM Internal Medicine, which is based on China demographics. This observational study integrates the concept of TCM diagnostic methods with modern tools aim to provide an objective view on the syndrome differentiation of diabetic and prediabetic patients in Singapore and hence provide a guideline in the treatment options targeted specifically at Singaporeans demographic. The investigators will attempt to recruit a total of 250 subjects with 50 allocated in each group to ensure a sufficient sample size for statistical analysis of the diabetic and prediabetic syndrome differentiation. Subjects aged 21-75 years old, of either gender, with no limitations on race, and is diagnosed with either diabetes (FPG ≥ 7.0 mmol/L, or 2hPG ≥ 11.1mmol) or prediabetes (IFG of FPG 6.1-6.9 mmol/L, and/or IGT with 2hPG of 7.8-11.0 mmol/L) will be included. Subjective and objective assessments through health evaluation, Physical Activity Questionnaire and Sugar Intake, Constitution in Chinese Medicine Questionnaire, radial pulse diagnosis and tongue diagnosis will be performed for each subject in a single visit. Statistical analysis of assessments will be conducted using unpaired t-test with significance level of p<0.05. Statistical software SPSS 15.0 (SPSS Inc.) will be used for the analysis.


Recruitment information / eligibility

Status Recruiting
Enrollment 250
Est. completion date December 31, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 75 Years
Eligibility Inclusion Criteria: - Aged 21-75 years old, inclusive; - Clinically diagnosed with one of the following: 1. Type II Diabetes Mellitus with or without hypertension and dyslipidemia 2. Prediabetes with or without hypertension and dyslipidemia 3. Healthy or sub-healthy subject without clinically diagnosed chronic conditions such as diabetes, hypertension or dyslipidemia Exclusion Criteria: - Subjects diagnosed with Gestational Diabetes - Subjects who are pregnant or lactating - Subjects with chronic heart failure, history of carcinomas with treatment of chemotherapy/radiotherapy, psychological, or psychiatric disorders - Subjects with heart diseases and transplanted devices such as pacemakers; - Subjects with acute infections such as upper respiratory infections, acute gastroenteritis, or urinary tract infections; - Subjects unable to undergo evaluation with the pulse sphygmograph, tongue detection or complete the questionnaire; - Subjects with communication disorders - Subjects with gastroenterology diseases or are diagnosed with 'spleen and stomach deficiency' (????) - Subjects undergoing TCM treatment for diabetes or pre-diabetes within 1 week

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Questionnaires+Tongue diagnosis+Pulse diagnosis
Each subject will undergo questionnaires, tongue and pulse diagnosis using modern diagnostic tools

Locations

Country Name City State
Singapore Singapore Chung Hwa Medical Institution Singapore

Sponsors (2)

Lead Sponsor Collaborator
Singapore Chung Hwa Medical Institution Ministry of Health, Singapore

Country where clinical trial is conducted

Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Constitution in Chinese Medicine Questionnaire (CCMQ) The CCMQ, published by the China Association of Chinese Medicine in 2009, will be adopted to assess the body constitution of each subjects based on TCM principles [26]. Refer to Annex 3.
There are nine different types of body constitution, including (a) Normality; (b) Qi deficiency; (c) Yin deficiency; (d) Yang deficiency; (e) Phlegm-dampness; (f) Damp-heat; (g) Blood stasis; (h) Qi depressed; (i) Inherited special constitution.
Each subject will answer seven to eight questions in each category. The scoring algorithm indicates the likelihood of a specific type of body constitution with a higher score.
One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
Primary Physical Activity Questionnaire and sugar intake Level of physical activity related to the last three months will be recorded through the Physical Activity Questionnaire. Sugar intake includes sweet or carbonated drinks, desserts like chocolates and cakes, 0 - 2, 3 - 6, or more than 7 times a week will also be recorded. Refer to Annex 2.
This will help to identify the risk factors involved and identify the correlation between the body constitutions and various types of 'xiao-ke' based on TCM syndrome differentiation.
One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
Primary Pulse sphygmograph The Asia Plus Pen Pulse Analysis System Model PPAS-93 (Asia Plus Bio Tech Co., Ltd, Taiwan) would be used in the identification of RPPW of the subjects in this study.
The Asia Plus Pen Pulse Analysis System Model PPAS-93 (Figure 11) is a noninvasive device that consist of a high precision pressure sensor pen and a pulse analyzer. The 3D pulse detector is a handheld pen that digitalizes the biological signal of RPPW and provides a graphical analysis. The electronic device contains a high precision pressure sensor, a filter, an amplifier, and a signal recording card connected to signal analysis software. The frequency response is 0.1-50 Hz, and the sampling rate is 3000 Hz.
One-time assessment within 30mins after undergoing the questionnaires
Primary Tongue imaging device China Artificial Intelligence Health Status Identification System Model Number YZKJ-SMZY-1AI (Figure 12) will be used in the imaging and analysis of the subject's tongue.
The noninvasive device captures the image of the tongue through an inbuilt camera supported by LED lights within the device. A monitor that is connected to the imaging device would provide a live video feedback on the positioning of the tongue. The images of the subjects' face, tongue, and sublingual collaterals will then be compared and analyzed for the similarities against standard images of tongue analysis using an artificial intelligence system.
One-time assessment within 30mins after undergoing the questionnaires
Secondary Health Evaluation - Age Demographic information eg age in years will be collected. One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
Secondary Health Evaluation - Gender Demographic information eg gender will be collected. One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
Secondary Health Evaluation - Weight Weight in kilogram will be recorded One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
Secondary Health Evaluation - Height Height in meters will be recorded One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
Secondary Health Evaluation - BMI Weight in kilogram and height in meters will be aggregated to derive the BMI in kg/m^2. One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
Secondary Health Evaluation - blood sugar level Blood glucose in fasting, 2hPG or HbA1c (in mmol/L) results if available in patient's regular blood test report One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
Secondary Health Evaluation - Vital signs Vital signs including systolic blood pressure, diastolic blood pressure in mmHg One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
Secondary Health Evaluation - Radial pulse rate Vital signs including radial pulse rate (bpm) One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
Secondary Health Evaluation - Medications Western and Chinese medications and nutritional supplements consumed by the subjects will be recorded to identify possible intervention and correlation towards TCM syndrome differentiation. One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
Secondary Health Evaluation - Existing symptoms The existing symptoms of subjects will be recorded to identify the possible correlation towards TCM syndrome differentiation. One-time assessment within 30mins before undergoing the tongue and pulse diagnosis.
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1